neurokinin a (4-10), beta-ala(8)- has been researched along with ibodutant in 1 studies
Studies (neurokinin a (4-10), beta-ala(8)-) | Trials (neurokinin a (4-10), beta-ala(8)-) | Recent Studies (post-2010) (neurokinin a (4-10), beta-ala(8)-) | Studies (ibodutant) | Trials (ibodutant) | Recent Studies (post-2010) (ibodutant) |
---|---|---|---|---|---|
71 | 0 | 2 | 11 | 1 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altamura, M; Catalani, C; Catalioto, RM; Cialdai, C; Giuliani, S; Lecci, A; Maggi, CA; Meini, S; Patacchini, R; Tramontana, M; Valenti, C | 1 |
1 other study(ies) available for neurokinin a (4-10), beta-ala(8)- and ibodutant
Article | Year |
---|---|
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Topics: Aged; Animals; Binding, Competitive; Bronchoconstriction; Cell Membrane; CHO Cells; Colon; Cricetinae; Cricetulus; Dipeptides; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; Mice; Middle Aged; Muscle Contraction; Neurokinin A; Peptide Fragments; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Receptors, Neurokinin-2; Swine; Thiophenes; Vasoconstriction | 2006 |